SCHEMBL1972947

SCHEMBL1972947

[CH2]C(C)(C)C(C)CCCCCC

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.42
SPHK1 Q9NYA1 1/20 0.40
LMNA P02545 1/20 0.39
DNM1 Q05193 2/20 0.39
TSHR P16473 1/20 0.38
THRB P10828 1/20 0.38
ADH1B P00325 1/20 0.38
ADH1C P00326 1/20 0.38
ADH1A P07327 1/20 0.38
ADH4 P08319 1/20 0.38
ADH7 P40394 1/20 0.38
CA2 P00918 1/20 0.38
SMPD1 P17405 3/20 0.36
ACE2 Q9BYF1 1/20 0.36
GPR84 Q9NQS5 2/20 0.35
FDPS P14324 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6632947 1.00 OPRM1 (0.42) OPRM1SPHK1LMNADNM1TSHR
SCHEMBL18894365 1.00 OPRM1 (0.42) OPRM1SPHK1LMNADNM1TSHR
SCHEMBL6467303 1.00 OPRM1 (0.42) OPRM1SPHK1LMNADNM1TSHR
SCHEMBL1970771 0.98 OPRM1 (0.44) OPRM1SPHK1LMNADNM1TSHR
SCHEMBL1971978 0.90 DNM1 (0.36) OPRM1DNM1TSHRCA2FDPS
SCHEMBL23803921 0.80 OPRM1 (0.46) OPRM1SPHK1LMNADNM1TSHR
SCHEMBL6700324 0.80 OPRM1 (0.46) OPRM1SPHK1LMNADNM1TSHR
SCHEMBL6060338 0.80 OPRM1 (0.46) OPRM1SPHK1LMNADNM1TSHR
SCHEMBL615029 0.80 OPRM1 (0.46) OPRM1SPHK1LMNADNM1TSHR
SCHEMBL8066854 0.80 OPRM1 (0.46) OPRM1SPHK1LMNADNM1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11156619-B2 Fluorescent pH sensors and methods of preparing them ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2021-10-26 US disclosed
EP-3194371-B1 ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS AGENCY SCIENCE TECH & RES (SG) 2020-09-02 EP disclosed
US-10570097-B2 Antimicrobial imidazolium compounds AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2020-02-25 US disclosed
US-20190016684-A1 ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2019-01-17 US disclosed
US-10160728-B2 Antimicrobial imidazolium compounds AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2018-12-25 US disclosed
WO-2018136794-A1 FLUORESCENT PH SENSORS AND METHODS OF PREPARING AND USING THEM ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2018-07-26 WO disclosed
US-20170291877-A1 ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-10-12 US disclosed
CN-107108518-A Antibacterial imidazolium compounds 新加坡科技研究局 2017-08-29 CN disclosed
EP-3194371-A1 ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS Agency for Science, Technology and Research (SG) 2017-07-26 EP disclosed
US-9469662-B2 Process for preparing optically active biophosphinylalkanes BASF SE (DE) 2016-10-18 US disclosed
WO-2016043660-A1 ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2016-03-24 WO disclosed
CN-101240001-B 2' -fluoro nucleosides UNIV EMORY 2013-10-16 CN disclosed
EP-1913007-B1 PROCESS FOR PREPARING OPTICALLY ACTIVE DIPHOSPHANES BASF SE (DE) 2011-06-22 EP disclosed
US-20080242893-A1 Process for Preparing Optically Active Diphosphanes BASF AKTIENGESELLSCHAFT (DE) 2008-10-02 US disclosed
EP-1913007-A1 PROCESS FOR PREPARING OPTICALLY ACTIVE DIPHOSPHANES BASF SE (DE) 2008-04-23 EP disclosed
WO-2007012655-A1 PROCESS FOR PREPARING OPTICALLY ACTIVE DIPHOSPHANES BASF SE (DE) 2007-02-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10570097-B2 Antimicrobial imidazolium compounds CCNI, MACF1, ECI1 OPRM1 1453/4885SPHK1 3784/4885LMNA 1163/4885
US-11156619-B2 Fluorescent pH sensors and methods of preparing them PHF8, PHF6, H1-0 OPRM1 2560/4885SPHK1 2765/4885LMNA 577/4885
US-10160728-B2 Antimicrobial imidazolium compounds CCNI, MACF1, ECI1 OPRM1 1453/4885SPHK1 3784/4885LMNA 1163/4885
US-20170291877-A1 ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS CCNI, MACF1, ECI1 OPRM1 1453/4885SPHK1 3784/4885LMNA 1163/4885
US-20190016684-A1 ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS CCNI, MACF1, ECI1 OPRM1 1453/4885SPHK1 3784/4885LMNA 1163/4885
US-20080242893-A1 Process for Preparing Optically Active Diphosphanes PHOSPHO1, DCTPP1, DCPS OPRM1 477/4885SPHK1 485/4885LMNA 3376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.